home > drugs a-z list > pulmozyme (dornase alfa) drug center

Pulmozyme

font size

Pulmozyme Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Pulmozyme Prescribing Information: Indications & Dosage

Daily administration of Pulmozyme® (dornase alfa) (dornase alpha) Inhalation Solution in conjunction with standard therapies is indicated in the management of cystic fibrosis patients to improve pulmonary function. In patients with an FVC ≥ 40% of predicted, daily administration of Pulmozyme (dornase alfa) has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics.

Safety and efficacy of daily administration have not been demonstrated in patients for longer than 12 months.

Read the complete drug monograph for Pulmozyme »

What is Pulmozyme Prescribing Information?

Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Pulmozyme Patient Information: Side Effects

If you experience any of the following serious side effects while taking dornase alfa, seek emergency medical attention or contact your doctor immediately:

  • an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
  • increased difficulty breathing;
  • chest pain; or
  • fever.

Less serious side effects may be more likely to occur with the use of dornase alfa. Talk to your doctor if you experience any of the following side effects:

  • voice alteration;
    • ...

Read the complete patient information for Pulmozyme »

What is Pulmozyme Patient Information?

Possible Side Effects - Images - What Is - How Should I Take It - What If I Miss a Dose - What Should I Avoid and More

What is Consumer information?

A concise overview of the drug for the patient or caregiver from First DataBank.

Pulmozyme Consumer Information: Uses

This medication is used to improve breathing and reduce the risk of lung infections in people with cystic fibrosis. It is used along with other treatments for this disease (e.g., chest physical therapy, medications, nutritional supplements). Dornase alfa is the same as a substance (DNase I enzyme) that is naturally produced by the body. It works in the airways by decreasing stickiness/thickness of mucus so that it can be cleared from the lungs more easily.

HOW TO USE: This medication is inhaled into the lungs using special breathing equipment, usual...

Read the complete consumer information for Pulmozyme »

What is Pulmozyme Consumer Information?

Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More

Related Resources for Pulmozyme

© Pulmozyme Patient Information is supplied by Cerner Multum, Inc. and Pulmozyme Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Additional Pulmozyme Information

Pulmozyme - User Reviews

Pulmozyme User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Pulmozyme sorted by most helpful. Patient Discussions FAQs

See User Reviews

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Privacy Policy

Women's Health

Find out what women really need.


From WebMD

Parenting & Children's Health Resources
Featured Centers